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Abstract Magnetic hyperthermia has been used for many
years to treat a variety of malignant tumors. One of the
problems in magnetic hyperthermia is the choice of the
correct particle concentration to achieve a defined temper-
ature increase in the tumor tissue. In this study, we evalu-
ated magnetic heat distribution induced by Fe3O4-APTMS
magnetic nanoparticles in agar tissue phantom when it
subjected to the AC magnetic filed. Using the correct
nanoparticle dosage and considering their specific loss
power, it is possible to estimate the efficiency of this ther-
apeutic method. The experimental data were compared with
a computer-based model, which were created using COM-
SOL Multiphysics to simulate the heat dissipation within
the tissue for typical configurations of the tumor position as
well as particle distribution within the tumor. Heating the
cancer cells up to 50C for 10 min was sufficient for
complete cell killing and the heat dose of 19.9 W/gtissue is
required for 5-mm tumor. Cell viability assay showed that
MNPs exhibited no significant cytotoxicity against HeLa
cells. Additionally, it was observed that the FITC-labeled
Fe3O4-APTMS MNPs presented high cell biocompatibility
and cellular uptake for efficient endocytosis.
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Introduction
The potency of magnetic nanoparticles (MNPs) as effective
heating agents for magnetic hyperthermia has been dem-
onstrated many years ago. Magnetic hyperthermia is based
on the fact that tumor cells are more sensitive than normal
tissue and significantly less able to tolerate the added stress
of heat in the range of 42–458C due to low oxygen, normal
acid concentrations, and insufficient nutrients (Cavaliere
et al. 1967; Dudar and Jain 1984; Halperin et al. 2007).
Higher temperatures up to 56C, which yield widespread
necrosis, coagulation, or carbonization (depending on
temperature), are called ‘thermoablation’. Hyperthermia is
advantageous in that it has fewer side effects than ther-
moablation, chemotherapy, or radiation, and it has been
investigated for many years in the treatment of a wide
variety of malignant tumors in both experimental animals
and patients (Tomitaka et al. 2009).
Magnetic hyperthermia refers to the introduction of
ferromagnetic or superparamagnetic particles into the tumor
tissue, followed by the application of an external varying
magnetic field. Superparamagnetic materials have zero
remanence and transform the energy of the magnetic field
into heat through two kinds of power loss mechanisms,
hysteresis loss and relaxation loss which include Brownian
relaxation and Neel relaxation (Ma et al. 2004; Maenosono
and Saita 2006). The efficiency of the transformation of
energy is strongly dependent on the strength and frequency
of the magnetic field and the properties of the magnetic
particles (Gazeau et al. 2008).
Recently, the use of magnetic sensitive agarose gel has
been explored for hyperthermia applications (Veverka et al.
2007; Okawa et al. 2006; Salloum et al. 2008). However,
the correct control of temperature has been a difficult and
complicated challenge. The reason for this problem may be
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explained mainly by insufficient administered heat dosage
against heat loss, resulting in entire target cancer tumors
not being heated up to tissue lethal temperature. The heat
dose administered in tissue takes into account two factors:
the heating power of magnetic material (W/gtissue) that is
represented by the specific absorption rate (SAR) (Jordan
et al. 1993), and the amount of magnetic nanoparticles
accumulated in the cancer region, which is represented by
the weight of particles per unit weight of target tumor
tissue (gmaterial/gtissue) (Yamada et al. 2010). The main issue
that we have to address is finding the objective heat dose
values which can overcome the amount of heat loss.
In the present study, to address the issue above, we
performed a systematical variation of tumor diameters and
particle dosages, and then observed the heat transfer pro-
cess within the agar tissue by employing a computer-con-
trolled heat simulator. Possibilities of achieving the
estimated heat dose by integrating presently available
technologies are discussed.
Experimental details
Synthesis of nanoparticle
In our experiment, we used Fe3O4-APTMS MNPs, where
the synthesis of Fe3O4 NPs were performed following the
procedure reported by (Park et al. 2004) and APTMS-
functionalized-Fe3O4 MNPs were prepared by the two-
step silanization process reported by (De Palma et al.
2007). For the binding of APTMS, 500 mg Fe3O4-oleic
acid NPs were dispersed in 100 ml toluene and placed in
a three neck flask. Subsequently, 5 ml APTMS and 5 ml
1 M TMAH were added and stirred under inert gas at
60C for 1 h. Precipitations were washed with toluene/
methanol (1:1), and the solvent was removed under vac-
uum. In the second step, the solid precipitates were dis-
solved in 100 ml mixture of toluene/ethanol (4:1), added
to 5 ml 1 M TMAH, and stirred and heated to 60C under
inert gas for 1 h. The solid precipitations were washed
with the same procedure as in step one. Finally, the
colloidal solution was dried under vacuum oven at 70C
for 3 h.
Characterization methods
The changes in the chemical groups present in the nano-
particles were monitored using FTIR spectrometry (JASCO
FT/IR 4100, USA). Particle size was measured using TEM
(JEOL, JEM-2010, Japan). Magnetic properties were
measured using SQUID (Quantum Design, MPMS XL 7.0,
USA).
Magnetic heating experiment
To verify the ability of heat generation by Fe3O4-APTMS
MNPs, we used a three turn coil (diameter 45 mm) which
was powered by an induction heating system (7.5 kW WI-
840, DIK, Korea) that generates a magnetic field (130 Oe,
154 kHz). To confirm the actual heat dose, 3 ml Fe3O4-
APTMS MNPs with four different concentrations of 10,
12, 15 and 17 mg/ml were placed in 35 mm cell culture
dishes. Thereafter, particles were concentrated in the
middle of the dish by applying permanent magnet. After
removing water, 3 ml agarose gel (1.2%) was added to
each dish. Samples were put in the middle of working
coil and temperatures at the upper surface of agar (5 mm
from the center of the MNPs) were measured by infrared
thermal imaging camera (FLIR 128 System, USA) during
the experiment. To investigate heat distribution in agar
tissue, the results were compared by heating sample
without agar gel.
Measurement of heating potential of Fe3O4-APTMS
represented by SAR
The magnitude of the SAR represents the heating power of
particles and defined according to (Hilger et al. 2002) as
SAR ½Wg1ðFe3O4-APTMSÞ ¼ Cgel
x
dT
dt
ð1Þ
where the specific heat of agarose gel Cgel is assumed to be
equal to the specific heat of water, i.e. 4.18 J/g C, and dT
(C)/dt (s) is the initial 30 s slope of the temperature versus
time curve. x is the weight fraction of magnetic elements in
gel according to the formula
x ¼ mðsample Fe3O4APTMSÞ
mðH2O) þ mðagaroseÞ ð2Þ
where m are the masses of Fe3O4-APTMS, H2O and aga-
rose, respectively.
Cytotoxic effect of heat at different temperature
generated by induction heating
Hyperthermic treatment of cultured cells was performed by
heating four cell pellets at various temperatures (38, 42, 55,
and 68C) for 10 min by direct immersion in a tempera-
ture-controlled water bath. Each heated cell pellet was
plated in a 60-mm cell-culture dish at the concentration of
1 9 104 cells/dish and cultured for 7 days. The number of
viable cells was evaluated by the trypan blue dye exclusion
method using a hemocytometer and was counted on days 1,
3, and 7. The data values and bars represent the mean and
SD of three independent experiments.
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Cell viability assay using WST-1
The cytotoxicity of Fe3O4-APTMS MNPs was measured
using the WST-1 assay (ITSBio, Korea). HeLa cells were
seeded at a density of 1 9 105 cells/well in 96-well plates
and incubated for 24 h. Fe3O4-APTMS with concentration
10, 12, 15, and 17 mg/ml were added into the culture
media in the plate. Untreated cells were used as controls.
Cells were incubated in a humidified 5% CO2 environment
at 37C for 12, 24, and 48 h, respectively. At the end of the
incubation time, 10 ll WST-1 solution was added to each
well. After 4-h incubation, plate was shaken for 1 min and
absorbance was measured using a microtiter plate reader
(Vmax, Molecular Device, USA) at 450 nm. Percentage
cell viability was calculated by
Cell viability ¼ mean test wells
mean control wells
 100% ð3Þ
Cell labeling using FITC
Fe3O4-APTMS MNPs were dispersed in 2 mL of ethanol,
and 0.1 mL FITC solution (1 mg/mL in DMSO) was added
to this solution. After shaking for 12 h in the dark, FITC-
conjugated Fe3O4-APTMS was obtained by washing with
ethanol and water and finally dispersed in water.
Subsequently, 1 ml of FITC-conjugated Fe3O4-APTMS
(1 mg/ml) was added to HeLa cells (1 9 105 cells/ml),
which were pre-cultured on a 12-well plate for 24 h at
37C. After 24-h exposure, the growth media was removed
and the cells were washed with PBS. Then, the cells were
re-incubated with a PBS solution with 3.7% formaldehyde.
FITC-conjugated Fe3O4-APTMS and cell nucleus were
monitored using fluorescence microscope.
Loss power density evaluation
Given the extrinsic (i.e., shape, diameter) and intrinsic (i.e.,
magnetization) properties of the particles and the intensity
value of the exciting magnetic field, a specific MATLAB
procedure was developed to obtain an estimate of the
effective power density (W/m3) originating from the con-
sidered magnetizing fluid. For a monodisperse solution,
this power is given by, (Rosensweig 2002):
P ¼ pl0v0H20 f
2pf s
1 þ ð2pf sÞ2 ð4Þ
In this equation l0 is the permeability of free space,
4p 9 10-7 Tm/A, H0 and f are the amplitude and the
frequency of alternating magnetic field, v0 = l0Ms
2V/(kBT),
Ms is the saturation magnetization, V is the particle volume,
and kB is the Boltzmann constant. The effective relaxation
time is given by s-1 = sN
-1 ? sB
-1, where sB and sN are the
Brownian and Ne´el relaxation time, respectively. Brownian
relaxation sB is neglected because it is *10
3 times larger
than the Neel relaxation time sN in agar gel (or in living
tissue) that has large viscosity (Okawa et al. 2006), where
sN equals
sN ¼ 2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
KV=kBT
p
ﬃﬃﬃ
p
p
s0 expðKV=kBTÞ ð5Þ
K is the anisotropy constant and s0 * 10
-9 s.
Computer-based model of heat transfer in biological
tissues
Using COMSOL Multiphysics ver 3.5, we intended to
compute the spatial temperature distribution within the
tissues. For our problem, the temperatures are dependent
on time and there is no fluid flow. The only mode of heat
transfer is by conduction. So the problem is a transient
conduction problem with no convection, the governing
equation that needs to be solved is
qCp
oT
ot
rðjrTÞ ¼ Q ð6Þ
where q is the density (kg/m3), Cp the molar specific heat at
constant pressure (J/kg/C), T the temperature (C), t the
time (s), j the thermal conductivity (W/m/C), Q the heat
generation rate (W/m3), and r means Laplacian. The 3D
symmetry model consists of a polystyrene cell-culture dish
with 1-mm thick walls, 5-mm thick homogenous agar tis-
sue layer and NPs which were located in the center of the
dish and on the bottom side before the agar tissue layer.
Fe3O4-APTMS MNPs with four different concentrations
(10, 12, 15 and 17 mg/ml) were modeled as a sphere with
0.5-mm thick wall and each concentration has different
diameter size (see Table 1). The physical properties of the
materials are presented in Table 2. Following our experi-
ment, the investigation was focused on the upper surface of
the agar where the verification of heat generation was
occurred by IR thermal imaging camera and it can only be
done on the upper surface of the agar.
The initial temperature was set at 20C. All surfaces of
the plate dishes were adjusted using initial temperature
except the bottom surface. Moreover, the thermal insula-
tion was applied on the agar surface and the surfaces along
Table 1 Loss power density values of four different concentrations
Fe3O4-APTMS MNPs
Concentration
(mg/gtissue)
Fe3O4-APTMS
diameter region (mm)
Loss power
density, P (W/m3)
10 8.2 2.07 9 106
12 10.0 4.99 9 106
15 11.0 6.26 9 106
17 12.6 8.38 9 106
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the symmetry line. The heat source was addressed on the
MNPs regions. In this study, the analysis time was set in
1,200 s. The models were constructed using tetrahedral
element. The UMFPACK direct solver and adequate con-
ditions needed for each calculation were automatically
selected by COMSOL.
Results
Fe3O4-APTMS MNPs characteristic
As previously established, Fe3O4 MNPs in the presence of
surfactants such as oleic acid are stable in non-polar solvents
(such as hexane) and capped with non-polar endgroups on
their surface (Jana et al. 2007). Therefore, to increase the
biocompatibility of MNPs, ligand exchange was needed to
tune surface properties to hydrophilic. Alkylsilanes was the
best candidate for its effectiveness and simplicity in con-
ducting the exchange of hydrophobic ligands on Fe3O4
MNPs and stabilization of nanoparticles (De Palma et al.
2007). The typical FT-IR spectra of Fe3O4 MNPs are shown
in Fig. 1a. The C=O at 1,711 cm-1, the C–H stretch at
2,911 cm-1, and the CH2/CH3 bending at 1,464 cm
-1 are
evidence of oleic acid-coated Fe3O4 MNPs. The FT-IR
spectra of Fe3O4-APTMS, see Fig. 1b, showed the peaks
around 1638 cm-1 ascribed to the –NH2 terminal of APT-
MS, the CH2 bending was found at 1,450 cm
-1, the C–H
stretch at 2,921 cm-1, the Si–O–Si bridges were seen at
1,098 cm-1, and the Si–O bound at 900 cm-1. The absence
of oleic acid peaks replaced by silane peaks in the Fe3O4
MNPs, indicates that ligand exchange was successfully
done.
TEM micrographs of Fe3O4-APTMS are shown in
Fig. 2. The results suggested that ligand exchange process
did not have significant effect on the particle size, both
Fe3O4-oleic acid and Fe3O4-APTMS MNPs had particle
size approximately 14 nm. It also can be seen that particles
were spherical in shape with a narrow size distribution and
uniform physico-chemical properties.
The SQUID data in Fig. 3 show the magnetic curves as
function of applied field at 300 K. The saturated magneti-
zation of Fe3O4-APTMS MNPs was about 38.4 emu/g,
which was lower than those of Fe3O4-oleic acid was about
57 emu/g. Moreover, the remanence (Mr) and coercivity
(Hc) were close to zero, exhibiting the characteristic of
Table 2 Physical properties of material applied in computer-based
simulation
Physical properties Fe3O4-
APTMSa
Agar
tissueb
Polystyrenec
Heat capacity (J/kg C) 670 4,183 1,300
Thermal conductivity
(W/m C)
6 0.6072 0.08
a (Maenosono and Saita 2006)
b (Veverka et al. 2007)
c (Chen et al. 2001)
Fig. 1 The FT-IR spectra of Fe3O4-oleic acid (a) and Fe3O4-APTMS
(b)
Fig. 2 TEM images Fe3O4-oleic acid (left) and Fe3O4-APTMS
(right)
Fig. 3 Magnetic hysteresis for Fe3O4-oleic acid (filled square) and
Fe3O4-APTMS (filled circles), measured at room temperature
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supramagnetism. Decrease of magnetization was related to
the high magnetocrystalline anisotropy of Fe3O4 in the
presence of APTMS, which formed polymerized multilayers
that suppress a tendency to destabilize magnetic ordering.
Increase of temperature in agar tissue containing
Fe3O4-APTMS MNPs when exposed to the magnetic
field
Figure 4 summarizes the results of our in vitro experiment
using 1.2% agar in a polystyrene cell culture dish con-
taining 10, 12, 15, and 17 mg Fe3O4-APTMS MNPs/gtissue.
When exposed to the magnetic field, the temperature
increased sharply. Within 20 min, Tc (maximum self-con-
trolled temperature at the center of particle) for Fe3O4-
APTMS MNPs was 38.4, 42.6, 55.1, and 68.1C,
respectively. Meanwhile, the upper surface temperatures of
agar tissue, at the region 5 mm from a center of the MNPs
sphere where observed to be lower than Tc of 34.5, 38.6,
49.1, and 61.4C, respectively. These decreases were
caused by heat losses of the system.
Heat doses used to agar tissue phantoms in vitro
to various equilibrium temperatures
To illustrate SAR as a function of MNPs content, their
values are plotted in Fig. 5. Since the nanoparticles are the
only heating sources present in the agar tissue, the SAR
distribution can be used as an index for the particle con-
centration in the gel. The temperature curve at upper sur-
face 5 mm away from the center of the MNPs is used to
determine the SAR values based on Eq. 1. For magnetic
field strengths 130 Oe, the SAR value was sensitive to the
concentration of Fe3O4-APTMS MNPs. 10 mg Fe3O4-
APTMS/gtissue corresponds to an applied heat dose of
14.9 W/gtissue. Similarly, 12, 15, and 17 mg Fe3O4-APT-
MS/gtissue corresponds to an applied heat dose of 15.9,
19.9, 25.0 W/gtissue, respectively. Herein, we obtained
some insight into the observed variation value of SAR. It
enables good automatic temperature control throughout the
tumor as a result of the self-regulating nature of the ther-
mosensitive materials. Moreover, the heat dose required to
increase the temperature of an in vitro tissue phantom
model up to 50C is in the range 19–25 W/gtissue.
Loss power density estimation and temperature
prediction
The estimated hysteresis power loss values were then used
as the heat source inside the agar tissue and the resulting
temperature rise in the whole hepatic region was evaluated
with COMSOL. Each concentration of MNPs was distrib-
uted in one spherical region whose diameter size was
depended on the amount of concentration. Calculating with
Fig. 4 Thermal response in agar surface. Temperature was observed
using IR camera. To show the heat transfer process in agar gel,
temperature was measured with and without agar. Fe3O4-APTMS
MNPs were concentrated in the middle using magnet with four
different concentrations a 10 mg/ml, b 12 mg/ml, c 15 mg/ml, and
d 17 mg/ml. The increase of temperatures was found to be
proportional to the quantity of the particles
Fig. 5 Equilibrium temperatures based on experiment at the region
of 5 mm from a center of the Fe3O4-APTMS MNPs sphere shown
34.5, 38.6, 49.1, and 61.4C, respectively. Error bars represent
standard deviations
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field magnitude H of 10.4 kA/m (130 Oe), frequency f of
154 kHz, and magnetization M 38.4 Am2/kg, the loss
power value of each spherical region is presented in
Table 2. The time-dependent changes in the temperature of
Fe3O4-APTMS MNPs heating are shown in Fig. 6. The
achieved temperature within 20 min for samples with
concentration of 10, 12, 15, and 17 mg Fe3O4-APTMS/
gtissue were 38.0, 42.8, 55.3, and 68.2C, respectively. Our
simulation showed close agreement to our experiment in
Fig. 4b. Further, the simulation results showed that in the
superparamagnetic behavior, the concentration of the par-
ticles is much more significant in determining the amount
of generated heat, as opposed to the parameters of field
amplitude and frequency.
Simulation of thermal gradient in vitro agar tissue
phantom
Figure 7a shows 3D thermal gradient simulation in agar
phantoms with Fe3O4-APTMS MNPs as heat source. The
resulting curves of achieved temperature in the x–z plane at
5 mm distance from it using a concentration of MNPs are
shown in Fig. 7b. When a heat dose of 14.9, 15.9, 19.9, and
25.0 W/gtissue were administrated, the temperature at the
centre of tissue increased to 34.0, 38.1, 48.8, and 61.0C,
respectively. These simulation data were quite comparable
to actual experimental data (Fig. 4), indicating the validity
of the COMSOL Multiphysics simulation results. To obtain
temperature higher than of 42.5C, concentration of Fe3O4-
APTMS MNPs of 15 mg/gtissue has been chosen.
Cytotoxic effect of heat
The number of viable cancer cells 1, 3, and 7 days after
exposure to four different temperatures is shown in Fig. 8.
The growth curves indicated that HeLa cells were rela-
tively sensitive to heating temperature. When cells were
heated at temperature of 38C, the number of cells growth
decreased significantly compared with the control. Further,
our results confirmed that exposure to temperature of 42C
can induce obvious cellular damage and it is agreed with
previous findings (Hickey and Weber 1982; Ito et al. 2004).
Moreover, exposures to temperatures of 55 and 68C were
more than enough to kill cells.
In vitro cell viability
The potential toxicity of Fe3O4-APTMS MNPs was dem-
onstrated by WST-1 cytotoxicity assay. This assay is based
Fig. 6 The time-dependent change in the temperature of Fe3O4-
APTMS MNPs obtained from computer simulation. The achieved
temperature within 20 min for samples with concentration of 10, 12,
15, and 17 mg Fe3O4-APTMS/gtissue were 38.0, 42.8, 55.3, 68.2C,
respectively
Fig. 7 Simulation of thermal gradient in agar gels (1.2%), which was heated with four different concentrations (left). The achieved temperature
in the x–z plane at 5 mm distance from center of Fe3O4-APTMS MNPs spheres (right)
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on the cleavage of the tetrazolium salt into water soluble
formazan by succinate-tetrazolium reductase system which
belongs to the respiratory chain of the mitochondria and
active only in the viable cells (Ishiyama et al. 1996).
Therefore, the amount of the formazan dye is directly
proportional to the number of living cells. The presence of
cell viability was examined after cells were incubated for
12, 24, and 48 h. WST-1 assay indicated viability greater
than 50% for all sample and were shown stable for each
incubation period, see Fig. 9. It means particles did not
have significant effect on cell viability and was categorized
as not toxic. The relationship to concentration indicates
that, at the highest concentration, the cells died more
quickly, and they died more slowly with decreasing
concentration.
Cellular uptake of FITC-labeled Fe3O4-APMTS
Confocal fluorescence scanning microscope (Leica Mi-
crosystem, Germany) was used to observe the uptake of
FITC-labeled Fe3O4-APTMS MNPs in HeLa cells after
12-h incubation is shown in Fig. 10. As shown, the fluo-
rescence (green) areas, after 12-h exposure, the FITC-
labeled Fe3O4-APTMS MNPs particles are present in
cytoplasm. Meanwhile, the HeLa cells treated by these
nanoparticles still remained large, spindle-shaped, which
reveals a nice biocompatibility of the synthesized Fe3O4-
APTMS MNPs.
Discussion and conclusion
We have developed a hyperthermia treatment protocol that
makes use of Fe3O4-APTMS MNPs designed to produce
heat for effective magnetic hyperthermia therapy. As
reported earlier (Oleson et al. 1989; Andra et al. 1999), the
temperature distribution is of great importance in deter-
mining how successful the treatment is. That is, how much
of the tumor is heated to therapeutic temperatures, and how
much of the surrounding normal tissue is damaged by the
heat.
Since many years ago, in vitro investigation of heat
generation in living tissue can be represented by agar,
where agar gel is equivalent as heat-sensitive gels for
phantom measurements and treatment verification purposes
(Siddiqi 2009). In this experiment, agar tissue was used as
the representative tumor to examine the amount of heat
dose provided by Fe3O4-APTMS MNPs. According to our
experimental result, for local magnetic hyperthermia using
Fe3O4-APTMS MNPs, a concentration of 12 mg/g tissue
and a SAR value 15.9 W/g tissue can be chosen. But a
large tumor with diameter more than 5 mm, may be treated
by applying heat dose of 19.9 W/g tissue, which resulted
from concentration of 15 mg/g tissue.
Before using the software COMSOL for present heat
simulation, we confirmed its reliability by comparing the
data obtained by using it with the experimental data. The
value of the loss power density is the basic input parameter
for COMSOL. The results showed that in the superpara-
magnetic behavior, the concentration of the particles is
much more significant in determining the amount of gen-
erated heat, as opposed to the parameters of field amplitude
and frequency. However, to obtain the same size for the
optimum temperature region for the same concentration of
Fig. 8 Cytotoxic effect of heat treatment in HeLa cell. After 10 min
exposure to various temperatures (38, 42, 55, and 68C), each cell
pellet was cultured for 7 days. The numbers of viable cells 1, 3, and
7 days after incubation were counted. The values and bars are the
mean and SD of three independent experiments
Fig. 9 In vitro cell viability of Fe3O4-APTMS, Fe3O4-APTMS-
cisplatin, chitosan, CS-cisplatin-Fe3O4, and cisplatin in HeLa cells
after 12, 24, and 48-h incubation time
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nanoparticles as in the superparamagnetic regime, we
observed that the field amplitude and frequency must be
significantly increased (Ang et al. 2007). By entering value
of magnetic field of 130 Oe (at 154 kHz) into COMSOL,
the simulated temperature at the center of sphere MNPs
(Fig. 6) was observed to be well correlated with those
detected experimentally (Fig. 4b). This result indicates that
COMSOL can be used in future studies for simulation of
temperatures in vivo.
The transfer of thermal energy in living tissues is a
complex process which involves both metabolic heat and
blood flow. For example, the blood flow within the tissue is
increased by thermoregulation to remove the heat supply
(Lyons et al. 1989; Pennes 1998), therefore the cooling
effect of blood flow should also be taken into consideration
in a clinical setting (Foster et al. 1978; Liu and Chen 2009).
It is true that the presence of blood flow acts as a heat
radiator and disrupts heating the tumor, however, we
eliminated blood flow issue from our estimation since this
obstacle may be overcome by employing a surgical tech-
nique known as Pringle’s manoeuvre (Pringle 1908) which
temporally occludes hepatic vascular inflow. The efficacy
of Pringle’s manoeuvre in reducing heat loss has been
clinically shown in radio-frequency ablation treatment
(Percivale et al. 2004). We therefore focused only on static
thermal diffusion loss to surrounding tissues as a heat loss
factor.
To define the required temperature for cancer cell kill-
ing, we demonstrated the influence of heating treatment on
cells growth. Since heat sensitivity of clinical cancers is
known to be variable, we used cell pellet to represent the
hard tumor tissue following the previous methods (Shinkai
et al. 1996; Yamada et al. 2010) and it was found that HeLa
cells are relatively sensitive to heating temperature. We
applied the treatment time at 10 min, since long irradiation
of AC magnetic field to living body tissue causes adverse
events (Ivkov et al. 2005). Our results (Fig. 8) demon-
strated that maintaining a temperature of 42C for 10 min
was insufficient and resulted in the reproliferation of cancer
cells, while a temperature of 55C maintained for 10 min
resulted in complete cell death regardless of the heat sen-
sitivity of each cell type.
Cytotoxicity measurements were originally designed for
rapid and inexpensive analysis of soluble pharmaceuticals.
They are also useful in the initial development of novel
nanoparticle formulations. As these results demonstrate,
the particular cytotoxicity assay selected could produce
erroneous findings due to nanoparticle-assay interference,
and thus careful experimental design is required to detect
potential interactions. In this study, WST-1 assays were
used to quantify cellular viability, rather than the formazan
product generated in the MTT assay (L’Azou et al. 2008).
When we applying MTT, Fe3O4-APTMS MNPs were
soluble in DMSO and it caused interferences in measure-
ment. Therefore, to avoid that, we assessed MNPs potential
cytotoxicity using WST-1 assay (Lu et al. 2006; Xu et al.
2008). According to our experimental data in Fig. 9, the
viability cells showed more than 50% for all concentrations
and these values are quite stable for all incubation periods.
Thus, we can ensure that APTMS surface modification of
Fe3O4 MNPs has non-toxic effect to the cell.
Here, we also examined the feasibility of using these
MNPs as an intracellular delivery carrier. FITC, an
extensively used fluorescent marker (Rossi et al. 2004;
Zhang et al. 2009) was used to label nanoparticles. The
results clearly demonstrated that these Fe3O4-APTMS
MNPs could serve as an efficient carrier by absorptive
endocytosis into the cell cytoplasm.
In conclusion, our results show that by using these
models, we can successfully estimate the impact of the
particle dose on the efficiency of hyperthermia therapy. It
could be thus a good method to evaluate the prospects of
the therapy for a given patient who has a well-described
condition and also to establish an optimum starting dose for
magnetic hyperthermia therapy in such a case. Moreover,
Fe3O4-APTMS MNPs exhibited good magnetic properties,
Fig. 10 Microscope images of HeLa cells after incubated with FITC-labeled Fe3O4-APTMS MNPs for 12 h. a Bright field represents phase
contrast, b green channel of fluorescence, and c overlay
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biocompatibility, low cytotoxicity and efficient endocyto-
sis. Thus, based on our obtained results, it can be concluded
that Fe3O4-APTMS MNPs will have excellent potential as
novel magnetic nanoparticles for hyperthermia.
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